I'm not usually a fan of companies rebranding, and whilst Neurizon is truly awful, PharmAust never really rolled off the tongue well either so why the hell not.
Now that all eggs are officially in one basket, let's hope they (and SH) are not left with it all over the you know where! Oncology market infinitely bigger than where they are headed, but also a much more crowded space.
I've offloaded all of my shares and just keeping options given the relatively long runway for conversion. Let's hope y'all's faith in MT is justified.
Ann: Notice of Annual General Meeting/Proxy Form, page-18
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $92.46M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.0¢ | 19.0¢ | $118.1K | 605.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 271759 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 84950 | 5 |
View Market Depth
| Last trade - 15.35pm 08/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |